F2RL3: Difference between revisions
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
m Bot: HTTP→HTTPS |
||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
{{ | '''Protease-activated receptor 4''' ('''PAR-4'''), also known as '''coagulation factor II (thrombin) receptor-like 3''', is a [[protein]] that in humans is encoded by the ''F2RL3'' [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: F2RL3 coagulation factor II (thrombin) receptor-like 3| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=9002| accessdate = }}</ref> | ||
| | |||
| | |||
| | |||
}} | |||
== Function == | |||
Coagulation factor II (thrombin) receptor-like 3 (F2RL3) is a member of the large family of 7-transmembrane-region receptors that couple to guanosine-nucleotide-binding proteins. F2RL3 is also a member of the [[protease-activated receptor]] family. F2RL3 is activated by proteolytic cleavage of its extracellular [[amino terminus]]. The new amino terminus functions as a tethered ligand and activates the receptor. F2RL3 is activated by [[thrombin]] and [[trypsin]].<ref name="entrez" /> | |||
==See also== | ==See also== | ||
Line 58: | Line 10: | ||
==References== | ==References== | ||
{{reflist | {{reflist}} | ||
==Further reading== | ==Further reading== | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
*{{cite journal |vauthors=Leger AJ, Covic L, Kuliopulos A |title=Protease-activated receptors in cardiovascular diseases. |journal=Circulation |volume=114 |issue= 10 |pages= 1070–7 |year= 2006 |pmid= 16952995 |doi= 10.1161/CIRCULATIONAHA.105.574830 }} | |||
*{{cite journal |vauthors=Xu WF, Andersen H, Whitmore TE |title=Cloning and characterization of human protease-activated receptor 4. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=95 |issue= 12 |pages= 6642–6 |year= 1998 |pmid= 9618465 |doi=10.1073/pnas.95.12.6642 | pmc=22580 |display-authors=etal}} | |||
*{{cite journal | | *{{cite journal |vauthors=Kahn ML, Zheng YW, Huang W |title=A dual thrombin receptor system for platelet activation. |journal=Nature |volume=394 |issue= 6694 |pages= 690–4 |year= 1998 |pmid= 9716134 |doi= 10.1038/29325 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Kahn ML, Hammes SR, Botka C, Coughlin SR |title=Gene and locus structure and chromosomal localization of the protease-activated receptor gene family. |journal=J. Biol. Chem. |volume=273 |issue= 36 |pages= 23290–6 |year= 1998 |pmid= 9722561 |doi=10.1074/jbc.273.36.23290 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Kahn ML, Nakanishi-Matsui M, Shapiro MJ |title=Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. |journal=J. Clin. Invest. |volume=103 |issue= 6 |pages= 879–87 |year= 1999 |pmid= 10079109 |doi=10.1172/JCI6042 | pmc=408153 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Andersen H, Greenberg DL, Fujikawa K |title=Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=96 |issue= 20 |pages= 11189–93 |year= 1999 |pmid= 10500152 |doi=10.1073/pnas.96.20.11189 | pmc=18009 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Sambrano GR, Huang W, Faruqi T |title=Cathepsin G activates protease-activated receptor-4 in human platelets. |journal=J. Biol. Chem. |volume=275 |issue= 10 |pages= 6819–23 |year= 2000 |pmid= 10702240 |doi=10.1074/jbc.275.10.6819 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Nakanishi-Matsui M, Zheng YW, Sulciner DJ |title=PAR3 is a cofactor for PAR4 activation by thrombin. |journal=Nature |volume=404 |issue= 6778 |pages= 609–13 |year= 2000 |pmid= 10766244 |doi= 10.1038/35007085 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Miike S, McWilliam AS, Kita H |title=Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2. |journal=J. Immunol. |volume=167 |issue= 11 |pages= 6615–22 |year= 2002 |pmid= 11714832 |doi= 10.4049/jimmunol.167.11.6615}} | ||
*{{cite journal | | *{{cite journal |vauthors=Asokananthan N, Graham PT, Fink J |title=Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. |journal=J. Immunol. |volume=168 |issue= 7 |pages= 3577–85 |year= 2002 |pmid= 11907122 |doi= 10.4049/jimmunol.168.7.3577|display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Henriksen RA, Hanks VK |title=PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets. |journal=Arterioscler. Thromb. Vasc. Biol. |volume=22 |issue= 5 |pages= 861–6 |year= 2002 |pmid= 12006403 |doi=10.1161/01.ATV.0000014742.56572.25 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Covic L, Singh C, Smith H, Kuliopulos A |title=Role of the PAR4 thrombin receptor in stabilizing platelet-platelet aggregates as revealed by a patient with Hermansky-Pudlak syndrome. |journal=Thromb. Haemost. |volume=87 |issue= 4 |pages= 722–7 |year= 2003 |pmid= 12008957 |doi= }} | ||
*{{cite journal | | *{{cite journal |vauthors=Strausberg RL, Feingold EA, Grouse LH |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal | author=Owen WG |title=PAR-3 is a low-affinity substrate, high affinity effector of thrombin. |journal=Biochem. Biophys. Res. Commun. |volume=305 |issue= 1 |pages= 166–8 |year= 2003 |pmid= 12732212 |doi=10.1016/S0006-291X(03)00732-0 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Adam F, Verbeuren TJ, Fauchère JL |title=Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP. |journal=J. Thromb. Haemost. |volume=1 |issue= 4 |pages= 798–804 |year= 2003 |pmid= 12871418 |doi=10.1046/j.1538-7836.2003.00138.x |display-authors=etal}} | ||
*{{cite journal | author= | *{{cite journal |vauthors=Wu CC, Hwang TL, Liao CH |title=The role of PAR4 in thrombin-induced thromboxane production in human platelets. |journal=Thromb. Haemost. |volume=90 |issue= 2 |pages= 299–308 |year= 2004 |pmid= 12888878 |doi= 10.1267/THRO03020299 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Kawai T, Akira S, Reed JC |title=ZIP kinase triggers apoptosis from nuclear PML oncogenic domains. |journal=Mol. Cell. Biol. |volume=23 |issue= 17 |pages= 6174–86 |year= 2003 |pmid= 12917339 |doi=10.1128/MCB.23.17.6174-6186.2003 | pmc=180930 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Jacques SL, Kuliopulos A |title=Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage. |journal=Biochem. J. |volume=376 |issue= Pt 3 |pages= 733–40 |year= 2004 |pmid= 13678420 |doi= 10.1042/BJ20030954 | pmc=1223816 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Han Y, Nurden A, Combrié R, Pasquet JM |title=Redistribution of glycoprotein Ib within platelets in response to protease-activated receptors 1 and 4: roles of cytoskeleton and calcium. |journal=J. Thromb. Haemost. |volume=1 |issue= 10 |pages= 2206–15 |year= 2004 |pmid= 14521606 |doi=10.1046/j.1538-7836.2003.00436.x }} | ||
*{{cite journal | | |||
}} | |||
{{refend}} | {{refend}} | ||
{{NLM content}} | {{NLM content}} | ||
{{G protein-coupled receptors}} | {{G protein-coupled receptors}} | ||
[[Category:Receptors]] | [[Category:Receptors]] | ||
[[Category:G protein coupled receptors]] | [[Category:G protein coupled receptors]] | ||
{{ | |||
{{transmembranereceptor-stub}} |
Revision as of 04:30, 31 August 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Protease-activated receptor 4 (PAR-4), also known as coagulation factor II (thrombin) receptor-like 3, is a protein that in humans is encoded by the F2RL3 gene.[1]
Function
Coagulation factor II (thrombin) receptor-like 3 (F2RL3) is a member of the large family of 7-transmembrane-region receptors that couple to guanosine-nucleotide-binding proteins. F2RL3 is also a member of the protease-activated receptor family. F2RL3 is activated by proteolytic cleavage of its extracellular amino terminus. The new amino terminus functions as a tethered ligand and activates the receptor. F2RL3 is activated by thrombin and trypsin.[1]
See also
References
Further reading
- Leger AJ, Covic L, Kuliopulos A (2006). "Protease-activated receptors in cardiovascular diseases". Circulation. 114 (10): 1070–7. doi:10.1161/CIRCULATIONAHA.105.574830. PMID 16952995.
- Xu WF, Andersen H, Whitmore TE, et al. (1998). "Cloning and characterization of human protease-activated receptor 4". Proc. Natl. Acad. Sci. U.S.A. 95 (12): 6642–6. doi:10.1073/pnas.95.12.6642. PMC 22580. PMID 9618465.
- Kahn ML, Zheng YW, Huang W, et al. (1998). "A dual thrombin receptor system for platelet activation". Nature. 394 (6694): 690–4. doi:10.1038/29325. PMID 9716134.
- Kahn ML, Hammes SR, Botka C, Coughlin SR (1998). "Gene and locus structure and chromosomal localization of the protease-activated receptor gene family". J. Biol. Chem. 273 (36): 23290–6. doi:10.1074/jbc.273.36.23290. PMID 9722561.
- Kahn ML, Nakanishi-Matsui M, Shapiro MJ, et al. (1999). "Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin". J. Clin. Invest. 103 (6): 879–87. doi:10.1172/JCI6042. PMC 408153. PMID 10079109.
- Andersen H, Greenberg DL, Fujikawa K, et al. (1999). "Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity". Proc. Natl. Acad. Sci. U.S.A. 96 (20): 11189–93. doi:10.1073/pnas.96.20.11189. PMC 18009. PMID 10500152.
- Sambrano GR, Huang W, Faruqi T, et al. (2000). "Cathepsin G activates protease-activated receptor-4 in human platelets". J. Biol. Chem. 275 (10): 6819–23. doi:10.1074/jbc.275.10.6819. PMID 10702240.
- Nakanishi-Matsui M, Zheng YW, Sulciner DJ, et al. (2000). "PAR3 is a cofactor for PAR4 activation by thrombin". Nature. 404 (6778): 609–13. doi:10.1038/35007085. PMID 10766244.
- Miike S, McWilliam AS, Kita H (2002). "Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2". J. Immunol. 167 (11): 6615–22. doi:10.4049/jimmunol.167.11.6615. PMID 11714832.
- Asokananthan N, Graham PT, Fink J, et al. (2002). "Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells". J. Immunol. 168 (7): 3577–85. doi:10.4049/jimmunol.168.7.3577. PMID 11907122.
- Henriksen RA, Hanks VK (2002). "PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets". Arterioscler. Thromb. Vasc. Biol. 22 (5): 861–6. doi:10.1161/01.ATV.0000014742.56572.25. PMID 12006403.
- Covic L, Singh C, Smith H, Kuliopulos A (2003). "Role of the PAR4 thrombin receptor in stabilizing platelet-platelet aggregates as revealed by a patient with Hermansky-Pudlak syndrome". Thromb. Haemost. 87 (4): 722–7. PMID 12008957.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Owen WG (2003). "PAR-3 is a low-affinity substrate, high affinity effector of thrombin". Biochem. Biophys. Res. Commun. 305 (1): 166–8. doi:10.1016/S0006-291X(03)00732-0. PMID 12732212.
- Adam F, Verbeuren TJ, Fauchère JL, et al. (2003). "Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP". J. Thromb. Haemost. 1 (4): 798–804. doi:10.1046/j.1538-7836.2003.00138.x. PMID 12871418.
- Wu CC, Hwang TL, Liao CH, et al. (2004). "The role of PAR4 in thrombin-induced thromboxane production in human platelets". Thromb. Haemost. 90 (2): 299–308. doi:10.1267/THRO03020299. PMID 12888878.
- Kawai T, Akira S, Reed JC (2003). "ZIP kinase triggers apoptosis from nuclear PML oncogenic domains". Mol. Cell. Biol. 23 (17): 6174–86. doi:10.1128/MCB.23.17.6174-6186.2003. PMC 180930. PMID 12917339.
- Jacques SL, Kuliopulos A (2004). "Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage". Biochem. J. 376 (Pt 3): 733–40. doi:10.1042/BJ20030954. PMC 1223816. PMID 13678420.
- Han Y, Nurden A, Combrié R, Pasquet JM (2004). "Redistribution of glycoprotein Ib within platelets in response to protease-activated receptors 1 and 4: roles of cytoskeleton and calcium". J. Thromb. Haemost. 1 (10): 2206–15. doi:10.1046/j.1538-7836.2003.00436.x. PMID 14521606.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
This transmembrane receptor-related article is a stub. You can help Wikipedia by expanding it. |